Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

drug resistance

  • Open Access
    Lurasidone Sensitizes Cancer Cells to Osimertinib by Inducing Autophagy and Reduction of Survivin
    SHUHEI SUZUKI, MASAHIRO YAMAMOTO, TOMOMI SANOMACHI, KEITA TOGASHI, SHIZUKA SEINO, ASUKA SUGAI, TAKASHI YOSHIOKA, MASASHI OKADA and CHIFUMI KITANAKA
    Anticancer Research September 2021, 41 (9) 4321-4331; DOI: https://doi.org/10.21873/anticanres.15237
  • You have access
    Estrogen Receptor β Is Involved in Acquired Resistance to EGFR-tyrosine Kinase Inhibitors in Lung Cancer
    HIROKI SUGIURA, YASUHIRO MIKI, ERINA IWABUCHI, RYOKO SAITO, KATSUHIKO ONO, IKURO SATO, YOSHINORI OKADA and HIRONOBU SASANO
    Anticancer Research May 2021, 41 (5) 2371-2381; DOI: https://doi.org/10.21873/anticanres.15012
  • You have access
    Biological Activity of a Thiobarbituric Acid Compound in Neuroblastomas
    SANG Y. LEE, BECKY SLAGLE-WEBB, ARUN K. SHARMA and JAMES R. CONNOR
    Anticancer Research March 2021, 41 (3) 1171-1181; DOI: https://doi.org/10.21873/anticanres.14874
  • You have access
    Urokinase-type Plasminogen Activator Is a Therapeutic Target for Overcoming Sorafenib Resistance in Hepatoma Cells
    MAMI OSAWA, YASUNOBU MATSUDA, YOSHIAKI KINOSHITA and TOSHIFUMI WAKAI
    Anticancer Research February 2021, 41 (2) 645-660; DOI: https://doi.org/10.21873/anticanres.14816
  • You have access
    Inhibition of Bruton's Tyrosine Kinase Suppresses Cancer Stemness and Promotes Carboplatin-induced Cytotoxicity Against Bladder Cancer Cells
    YUEH PAN, YA-HSU CHIU, SHAO-CHIH CHIU, DER-YANG CHO, LIANG-MING LEE, YU-CHING WEN, JACQUELINE WHANG-PENG, CHI-HAO HSIAO and PING-HSIAO SHIH
    Anticancer Research November 2020, 40 (11) 6093-6099; DOI: https://doi.org/10.21873/anticanres.14630
  • You have access
    Protein Profiling of Extracellular Vesicles Associated With Cisplatin Resistance in Lung Cancer
    HELIER BALBINOTTI, NATHAN A. CADORE, CRISTINE S. DUTRA, EDILEUZA D. DA SILVA, HENRIQUE B. FERREIRA, ARNALDO ZAHA and KARINA M. MONTEIRO
    Anticancer Research October 2020, 40 (10) 5509-5516; DOI: https://doi.org/10.21873/anticanres.14563
  • You have access
    Cell Cycle Dysregulation Is Associated With 5-Fluorouracil Resistance in Gastric Cancer Cells
    DA SOM KIM, KYOUNGMI MIN and SUK KYEONG LEE
    Anticancer Research June 2020, 40 (6) 3247-3254; DOI: https://doi.org/10.21873/anticanres.14306
  • You have access
    Effect of Small-molecule Tyrosine Kinase Inhibitors on PDGF-AA/BB and PDGFRα/β Expression in SCC According to HPV16 Status
    LENA HUBER, RICHARD BIRK, NICOLE ROTTER, CHRISTOPH ADERHOLD, ANNE LAMMERT, FREDERIC JUNGBAUER and BENEDIKT KRAMER
    Anticancer Research February 2020, 40 (2) 825-835; DOI: https://doi.org/10.21873/anticanres.14014
  • You have access
    Association of ABC Transporter With Resistance to FK866, a NAMPT Inhibitor, in Human Colorectal Cancer Cells
    YOKO OGINO, AKIRA SATO, YOHEI KAWANO, TAKAO AOYAMA, FUMIAKI UCHIUMI and SEI-ICHI TANUMA
    Anticancer Research December 2019, 39 (12) 6457-6462; DOI: https://doi.org/10.21873/anticanres.13859
  • You have access
    Apatinib Reverses Paclitaxel-resistant Lung Cancer Cells (A549) Through Blocking the Function of ABCB1 Transporter
    QUNCHENG ZHANG, YONGAN SONG, XIANGSONG CHENG, ZHIWEI XU, OLAJUYIN AYOBAMI MATTHEW, JIA WANG, ZHIFU SUN and XIAOJU ZHANG
    Anticancer Research October 2019, 39 (10) 5461-5471; DOI: https://doi.org/10.21873/anticanres.13739

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire